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Building a spindle pole
 
astillo et al. (page 453) have identified what may be a key
event in building the spindle pole body (SPB) of budding yeast. 
They found that the kinase Mps1p phosphorylates and thus helps 
organize Spc42p, an important component of the SPB central plaque.
Mps1p has been a difficult protein to study, as it does double duty 
as a regulator of SPB structure, and as part of the spindle checkpoint 
signal cascade. Previous conditional mutants have knocked out both 
functions, perhaps because the mutations have been focused in the 
catalytic domain of Mps1p. But Castillo et al. aim their mutagenesis 
at the essential NH
 
2
 
 terminus of the protein. They use a strain 
lacking Cin8p protein, as this condition makes the checkpoint 
essential, and thus ensures that any surviving mutant retains Mps1p 
checkpoint function.
The resulting SPB-assembly mutant, mps1–8, can be suppressed 
by overexpressed Spc42p. Spc42p coimmunoprecipitates with 
Mps1p, and is an in vitro substrate for its kinase activity. Finally, 
Mps1p is necessary for overexpressed Spc42p to form an extended 
super-plaque.
Mps1p is known to phosphorylate other SPB proteins at other 
times in SPB duplication. Thus Mps1p is one of several mitotic 
kinases that have multiple functions. The challenge now is to 
understand how these many functions are coordinated.
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Wild-type (left), but not mutant (right), Mps1p can make an 
Spc42p super-plaque.
 
GRASP65 gets the chop
 
arly in apoptosis, caspase 3 chops up the Golgi stacking 
protein GRASP65 to fragment the Golgi, according to 
results presented by Lane et al. on page 495. The 
fragmentation may cut the Golgi into manageable pieces, 
and allow dispersion of the pieces so that they can be 
incorporated into apoptotic bodies near the disintegrating 
plasma membrane.
Lane et al. map the relevant 
cleavage sites on GRASP65 
to the COOH terminus of the 
protein. A GRASP65 protein 
with these sites mutated is no 
longer cleaved, and the mutant 
protein preserves 
 
 
 
1/4 of the 
Golgi stacking after apoptosis 
induction. Given that GRASP65 
is located only in the cis Golgi, 
it might be expected to protect 
at most half of the Golgi from a 
loss of stacking. Lane et al. 
suspect that other caspase substrates control degradation of 
the rest of the Golgi, although they show that a number of 
other known Golgi stacking proteins are not cleaved during 
apoptosis.
The results with mutant GRASP65 underscore the in vivo 
importance of GRASP65 in construction of the Golgi, which 
was previously only hinted at in in vitro assays. This function 
may be performed by the cleavable COOH terminus of the 
protein, whereas the vesicle tethering function of GRASP65 
relies on the NH
 
2
 
 terminus. The mechanisms by which the 
COOH terminus carries out its job, including any protein 
partners, remain unknown. 
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Apoptotic cells (red) lack 
GRASP65 (green).
 
With A
 
 
 
, the danger lies within
 
he most obvious symptom is not always the most relevant. 
In Alzheimer’s disease (AD), for example, post-mortem  T
 
brain analyses show large extracellular 
amyloid plaques of fibrillar A
 
 
 
 protein. But 
the plaques arise late, whereas an intracellular 
version of the toxic protein fragment (A
 
 
 
1–42
 
, 
a fragment of the amyloid precursor protein) is 
seen earlier, coincident with the first cognitive 
defects. Now Zhang et al. (page 519) show 
that minute amounts of this intracellular 
A
 
 
 
1–42
 
 are toxic to primary neurons, even 
when injected directly into the cytoplasm.
The final concentration of injected A
 
 
 
1–42
 
 is 
1–100 pM, for a total of somewhere between 
Intracellular injection of A 1–42 
induces neuronal cell death 
and TUNEL staining (green).
 
1,500 and 150,000 molecules per neuron. In contrast, the 
same neurons are not significantly affected by up to 10 
 
 
 
M 
extracellular A
 
 
 
1–42
 
, nor by intracellular A
 
 
 
1–40
 
, perhaps because 
the A
 
 
 
1–40
 
 cannot multimerize. Death requires transcription and 
translation, and the activities of p53, Bax, and 
caspase 6, probably in that order. The pathway 
from A
 
 
 
1–42
 
 to p53 remains a mystery. Zhang 
et al. are now looking at kinases that are 
known to regulate p53 activity.
What goes wrong first in AD is also not 
clear. If A
 
 
 
1–42
 
 exerts its activity in the cyto-
plasm it must first escape from the secretory 
pathway. Zhang et al. suggest this may 
happen by either reverse translocation from 
the ER or leakage from endosomes. As the 
details of these pathways are fleshed out, 
both the trafficking and apoptotic pathways may become 
excellent targets for AD drugs. 
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